Research
Marshmallow Root (Althaea officinalis)
5 peer-reviewed studies curated from PubMed and Semantic Scholar.
Studies
Sorted by quality and recency
The efficacy of complementary treatment with marshmallow (Althaea officinalis L.) on vulvovaginal candidiasis: A randomized double-blinded controlled clinical trial.
RCT comparing marshmallow aqueous extract 4% plus clotrimazole 1% (CLOT-M) to clotrimazole 1% vaginal creams in 100 women with vulvovaginal candidiasis. CLOT-M showed significant improvement in symptoms like itching, dyspareunia, and dysuria compared to clotrimazole alone, with no significant adverse events.
A randomized, open-label, multicenter, comparative study of therapeutic efficacy, safety and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb in the treatment of acute non-bacterial tonsillitis in children aged 6 to 18 years.
This randomized, open-label, multicenter study assessed the efficacy of BNO 1030 (Imupret®), a phytoneering extract, in treating acute non-bacterial tonsillitis in children aged 6-18 years. The study found that BNO 1030 significantly reduced tonsillitis symptoms and improved general condition starting from day 2, with a high percentage of treatment responders and no adverse reactions.
To evaluate the efficacy and safety of CofNovex plus (EMA) syrup.
RCT conducted in 220 patients comparing CofNovex plus (EMA) syrup to placebo for treating cough and cold symptoms. The syrup, containing herbal ingredients like Ivy leaf, was effective and well tolerated in patients aged 3 years and above.
Comparison between three different saliva substitutes in patients with hyposalivation.
RCT comparing the efficiency of Buccotherm, Xeros, and marshmallow root on quality of life in 60 patients with hyposalivation. Buccotherm showed the biggest effect on quality of life, but all substitutes decreased the intensity of dry mouth symptoms.
The evaluation ofefficacy and safety of Cough (EMA) granules used for upper respiratory disorders.
RCT evaluating the efficacy and safety of Cough (EMA) granules, containing ivy leaf, marshmallow, and mustard seeds, in 150 patients with upper respiratory disorders. The granules were effective in treating cough, cold, and flu symptoms and were well tolerated.